Chronic kidney disease: open trials in South Africa

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Bellville · Benoni · Bloemfontein · Cape Town · Durban · Johannesburg · KwaDukuza · Lenasia · Midrand · Newton · Parow

  Registry updated 2026-11-06

• NCT07241390

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Tread Research, Cape Town · Soweto Clinical Trials Centre, Johannesburg · Paarl Research Centre, Paarl · Mediclinic Vergelegen, Sommerset West · Clinical Projects Research, Worcester

  Registry updated 2026-11-04

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Bloemfontein

  Registry updated 2026-10-05

• NCT05457283

  A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

  Trial Treatment · Phase 3 · Bayer

  Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Soweto

  Registry updated 2026-09-24

• NCT03549754

  iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

  Research · AstraZeneca

  Florida · Parow · Umhlanga

  Registry updated 2026-09-09

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error